Magainins: The Frog Skin Peptides That Kill Bacteria, Fungi, and Parasites
Scientists discovered a new class of antimicrobial peptides in frog skin that can kill bacteria, fungi, and protozoa without harming blood cells.
Quick Facts
What This Study Found
Two closely related 23-amino-acid peptides called magainins were isolated from the skin of the African clawed frog (Xenopus laevis). These peptides kill numerous species of bacteria and fungi at low concentrations, lyse protozoa through osmotic disruption, and are water-soluble and nonhemolytic — meaning they destroy microbes without damaging red blood cells.
Both peptides derive from a common precursor protein, as confirmed by partial cDNA sequencing. They differ by only two amino acid substitutions and are potentially amphiphilic (having both water-loving and fat-loving regions), which likely explains how they interact with microbial membranes.
Key Numbers
Two peptides, each 23 amino acids; differ by 2 substitutions; broad-spectrum activity against bacteria, fungi, and protozoa; nonhemolytic at antimicrobial concentrations; derived from common precursor protein
How They Did This
The researchers isolated peptides from the skin of Xenopus laevis frogs using high-pressure liquid chromatography. They characterized two active peptide forms, determined their amino acid sequences, tested antimicrobial activity against multiple bacterial, fungal, and protozoal species, checked for hemolytic toxicity, and obtained partial cDNA sequence of the precursor protein.
Why This Research Matters
This 1987 paper is a landmark in antimicrobial peptide research. It was the first to characterize magainins — a discovery that launched an entire field of study into natural antimicrobial peptides as potential alternatives to conventional antibiotics. The finding that a vertebrate animal produces broad-spectrum antimicrobial peptides in its skin opened the door to understanding innate immune defense across species and inspired decades of drug development efforts.
The Bigger Picture
This paper is one of the founding studies of the antimicrobial peptide field. The discovery of magainins showed that vertebrates produce their own natural antibiotics, an insight that reshaped our understanding of innate immunity. In the decades since, thousands of antimicrobial peptides have been identified across species, and several have entered clinical development as potential alternatives to conventional antibiotics — especially important as antibiotic resistance grows worldwide.
What This Study Doesn't Tell Us
This is an in vitro characterization study from 1987. Antimicrobial activity was demonstrated in laboratory conditions, not in living organisms. The mechanism of action was proposed but not directly demonstrated. Clinical applicability to human infections was not tested.
Questions This Raises
- ?Can magainins or their synthetic derivatives be developed into effective drugs for human infections?
- ?What is the exact mechanism by which these amphiphilic peptides destroy microbial membranes while sparing host cells?
- ?Do other vertebrate species produce similar skin-based antimicrobial peptides?
Trust & Context
- Key Stat:
- 23-amino-acid natural antibiotics Frog skin peptides killed bacteria, fungi, and protozoa at low concentrations without damaging red blood cells
- Evidence Grade:
- This is a foundational laboratory study that characterized a new class of molecules. While it doesn't include clinical or even animal treatment data, its importance lies in the discovery itself — it opened an entirely new field of antimicrobial research.
- Study Age:
- Published in 1987, this is a seminal paper that launched the modern field of antimicrobial peptide research. Its findings remain highly relevant as the foundation for ongoing work in peptide-based antibiotics.
- Original Title:
- Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.
- Published In:
- Proceedings of the National Academy of Sciences of the United States of America, 84(15), 5449-53 (1987)
- Authors:
- Zasloff, M
- Database ID:
- RPEP-00063
Evidence Hierarchy
Frequently Asked Questions
Why are frog skin peptides relevant to human medicine?
Frogs produce antimicrobial peptides as part of their natural immune defense. Studying these peptides has helped scientists understand how nature fights infections and has inspired the design of new synthetic antibiotics — particularly important as bacteria become increasingly resistant to existing drugs.
What happened to magainins after this discovery?
Magainins sparked an entire field of research. A synthetic derivative called pexiganan reached Phase III clinical trials for diabetic foot infections, and thousands of other antimicrobial peptides have since been discovered and studied across many species.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00063APA
Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.. Proceedings of the National Academy of Sciences of the United States of America, 84(15), 5449-53.
MLA
Zasloff, M. "Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.." Proceedings of the National Academy of Sciences of the United States of America, 1987.
RethinkPeptides
RethinkPeptides Research Database. "Magainins, a class of antimicrobial peptides from Xenopus sk..." RPEP-00063. Retrieved from https://rethinkpeptides.com/research/zasloff-1987-magainins-a-class-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.